Nirogya Retail Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 62.70%
- Profit Growth 59.68%
- Ebitda 166.18%
- Net Worth 48.81%
- Total Assets 114.45%
About Nirogya Retail Medicines
Nirogya Retail Medicines Private Limited (NRMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and four months 14 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Anju Baranwal and Rajesh Baranwal serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52609MP2018PTC046609
-
Company No.
046609
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Nirogya Retail Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anju Baranwal
|
Director | 20-Sep-2018 | Current |
|
Rajesh Baranwal
|
Director | 20-Sep-2018 | Current |
Financial Performance of Nirogya Retail Medicines.
Nirogya Retail Medicines Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.7% increase. The company also saw a substantial improvement in profitability, with a 59.68% increase in profit. The company's net worth Soared by an impressive increase of 48.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirogya Retail Medicines?
In 2023, Nirogya Retail Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nicolan Healthcare Private LimitedRajesh Baranwal is a mutual person
-
Medi Basket Private LimitedAnju Baranwal and Rajesh Baranwal are mutual person
-
Rajvir Pharma Private LimitedRajesh Baranwal is a mutual person
-
Medihub Enterprises Private Limited
Rajesh Baranwal is a mutual person
-
Discount Forever Private Limited
Rajesh Baranwal is a mutual person
-
Exilis Pharma Private Limited
Rajesh Baranwal is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2023 | Others | ₹5.00 M | Open |
How Many Employees Work at Nirogya Retail Medicines?
Unlock and access historical data on people associated with Nirogya Retail Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirogya Retail Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirogya Retail Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.